Inactive Instrument

News Alliance Pharma plc

Equities

APH

GB0031030819

Pharmaceuticals

Alliance Pharma Delists from London Bourse's AIM After Acquisition	05-15	MT
Aegros Bidco Completes Takeover of Alliance Pharma	05-14	MT
Alliance Pharma Says Aegros Bidco Recommends Acquisition Of Alliance Pharma	05-14	RE
Alliance Pharma plc Announces the Termination of Camillo Pane as Director, Effective May 14, 2025	05-13	CI
Alliance Pharma plc Announces the Termination of Mr. Richard Alexander Mckenzie as Director, Effective from May 14, 2025	05-13	CI
Alliance Pharma Plc Announces the Termination of Martin Sutherland as Director, Effective May 14, 2025	05-13	CI
Alliance Pharma plc Announces the Termination of Kristof Leon Neirynck as Director, Effective from May 14, 2025	05-13	CI
Alliance Pharma plc Announces the Termination of Richard Crispin Jones as Director, Effective from May 14, 2025	05-13	CI
Alliance Pharma Plc Announces the Termination of Eva-Lotta Saga Sjostedt as Director, Effective May 14, 2025	05-13	CI
An undisclosed funds, managed by DBAY Advisors Limited, An undisclosed funds, managed by Baring Asset Management Limited, Edmond De Rothschild Equity Strategies IV Fund, a fund managed by Edmond de Rothschild Private Equity Management Ltd. and an undisclosed buyer completed the acquisition of remaining 71.9% stake in Alliance Pharma plc from Andrew Franklin, Richard Jones, Nick Sedgwick, Slater Investments Limited and others.	05-13	CI
Aegros' Takeover of Alliance Pharma Sanctioned by Court	05-13	MT
Form 8.3 - [ALLIANCE PHARMA PLC - 08 05 2025] - (CGWL)	05-09	AQ
Form 8.3 - [ALLIANCE PHARMA PLC - 06 05 2025] - (CGWL)	05-07	AQ
Form 8.3 - [ALLIANCE PHARMA PLC - 28 04 2025] - (CGWL)	04-29	AQ
Slater Investments Discloses 4.37% Stake In Alliance Pharma As Of 25-Apr-2025	04-29	RE
Form 8.3 - [ALLIANCE PHARMA PLC - 17 04 2025] - (CGWL)	04-22	AQ
Form 8.3 - [ALLIANCE PHARMA PLC - 16 04 2025] - (CGWL)	04-17	AQ
Form 8.3 - [ALLIANCE PHARMA PLC - 08 04 2025] - (CGWL)	04-09	AQ
Alliance Pharma : Final Results for the year ended 31 December 2024 Reports	04-09	PU
Alliance Pharma : Preliminary Results for the year ended 31 December 2024 Reports	04-09	PU
Form 8.3 - [ALLIANCE PHARMA PLC - 07 04 2025] - (CGWL)	04-08	AQ
Alliance Pharma loss narrows in 2024 due to reduced impairment charges	04-08	AN
Alliance Pharma : Preliminary Results for the year ended 31 December 2024 Press	04-08	PU
Alliance Pharma : Preliminary Results for the year ended 31 December 2024	04-08	PU
Alliance Pharma Says Group Performance In Three Months To End March In-Line With Expectations	04-08	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Alliance Pharma plc

Equities

APH

GB0031030819

Pharmaceuticals

Filters